GEM-231 | m-entrepreneurship.com

Product Name :
GEM-231

Search keywords :
GEM-231

drugId :
null

Target Vo:
cAMP-dependent protein kinase type I-alpha regulatory subunit

Target Vo Short Name :
PRKAR1A

Moa_Name:
cAMP-dependent protein kinase type I-alpha regulatory subunit inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Idera Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Solid tumours

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FOXO4 Antibody
Calnexin Antibody (YA573)
CALCRL Antibody: CALCRL Antibody is an unconjugated, approximately 50 kDa, rabbit-derived, anti-CALCRL polyclonal antibody. CALCRL Antibody can be used for: WB, ELISA expriments in human, mouse, and predicted: rat background without labeling.

Author: Betaine hydrochloride

Related Posts